Skip to main content
. 2021 Oct 9;36(3):772–780. doi: 10.1038/s41375-021-01442-8

Fig. 4. PFS after first rrHL according to the RFs stage IV, refractory disease and GHSG risk group at 1st-diagnosis.

Fig. 4

A stage IV vs. stage I-III at rrHL, B: refractory disease vs. TTR > 3 months, C PFS at rrHL according to risk-group at 1st diagnosis. PFS progression-free survival, rrHL relapsed or refractory Hodgkin lymphoma, RFs risk factors.